Issues related to drug pricing and reimbursement for prescription drugs
2026 · 2nd Quarter (Apr 1 - June 30)
TAKEDA PHARMACEUTICALS AMERICA, INC.
Filed by AVENUE SOLUTIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- AVENUE SOLUTIONS
- Filing UUID
- 9709401e-60da-4331-9f19-2ccdeeb302e0
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.